Esclerosis Múltiple
Buscador de publicaciones
Sólo se han incluido artículos originales, editoriales y revisiones.
-
Domínguez-Ruiz M, Chico JL, López-Marín L, Stanescu S, Crujeiras P, Rodrigues D, Heras-Alonso ML, Torremocha R, Meijón-Ortigueira MDM, Muñoz-Díez P, Lanza VF, Colón C, Villarrubia J, Belanger A, Castillo FJD.
Abnormal Splicing of GALC Transcripts Underlies Unusual Cases of Krabbe Disease
Biomedicines . 13(12): .
-
Landete L, Gómez-Ballesteros R, Meca-Lallana V, Caminero AB, Meca-Lallana JE, Martínez-Yélamos S, García-Domínguez JM, Agüera E, García-Arcelay E, Medrano N, Villar LM, Monreal E, Maurino J.
How do neurologists perceive the organization and functioning of multiple sclerosis care units?
MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL . 11(4): .
-
Rodero-Romero A, Domínguez-Mozo M, Monreal E, García-Domínguez JM, Villarrubia N, Fernández-Velasco JI, Comabella M, de la Maza SS, Goicochea Briceño H, Chico-García JL, García-Martínez MÁ, Rodriguez-Jorge F, Veiga-Gonzalez JL, Sainz-Amo R, Martínez Ginés ML, Montalban X, Masjuan J, Costa-Frossard L, Álvarez-Lafuente R, Villar LM.
New serum soluble factors predicting inflammatory and non-inflammatory disability worsening in multiple sclerosis
Frontiers in immunology . 16: 1729500-1729500.
-
González-Gay MÁ, Gómez-Bernal F, Quevedo-Abeledo JC, Almeida-Santiago C, Heras-Recuero E, Torres-Roselló A, de Vera-González A, Tejera-Segura B, García-Barrera E, Blázquez-Sánchez T, Villar LM, Ocejo-Vinyals JG, Largo R, Ferraz-Amaro I.
Ultrasensitive quantification of serum IFN-a and IFN-? in systemic lupus erythematosus: A cross-sectional observational study
PLOS MEDICINE . 22(12): .
-
González-Gay MÁ, Gómez-Bernal F, Heras-Recuero E, Quevedo-Abeledo JC, De Vera-González A, Tejera-Segura B, Gómez-Moreno C, García-Barrera E, Villar LM, Ocejo-Vinyals JG, Largo R, Ferraz-Amaro I.
Ultrasensitive serum interleukin-8 levels show no association with disease activity or autoantibody profile but relate to cardiovascular comorbidity in systemic lupus erythematosus.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY . : .
-
Keller CW, Stein K, Vilaseca A, Villar LM, Álvarez-Bravo G, Protopapa M, Shin J, Fissolo N, Martínez-Rodríguez JE, Quiroga-Varela A, García-Sarreón A, Gutiérrez L, Midaglia L, Montalban X, Lünemann JD, Comabella M.
Reduced CD40 expression in B cell subsets of individuals with radiologically isolated syndrome
Frontiers in immunology . 16: 1680233-1680233.
-
Muñoz-Reyes D, Aguado L, Arroyo-Urea S, Requena C, Pérez-Suárez S, Sánchez-Yepes S, Argerich J, Miró-Rodríguez C, Ulzurrun E, Rodríguez-Martín E, García-Nafría J, Campillo NE, Mansilla A, Sánchez-Barrena MJ.
FDA Drug Repurposing Uncovers Modulators of Dopamine D2 Receptor Localization via Disruption of the NCS-1 Interaction
JOURNAL OF MEDICINAL CHEMISTRY . 68(22): 23993-24010.
-
Torres Iglesias G, Chavarría-Miranda A, López-Molina M, Del Fresno C, Mata-Martínez P, Nozal P, Chico-Garcia JL, Fernández-Fournier M, Lacruz Ballester L, Sanchez D, Montero-Calle A, Barderas R, Bravo S, Puertas I, York E, Díez-Tejedor E, Gutiérrez-Fernández M, Otero-Ortega L.
Extracellular Vesicles as Novel Biomarkers for Tumor Association in Intermediate-Risk Paraneoplastic Neurologic Syndromes
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION . 12(6): .
-
El Mahdaoui S, Kosa P, Komori M, Veiga González JL, Chow HH, Ratzer R, Madsen CG, Siebner HR, Bielekova B, Villar LM, Romme Christensen J, Sellebjerg F.
Profiling the Cerebrospinal Fluid Proteome in Progressive Multiple Sclerosis: Treatment Effects and Associations with IgM Oligoclonal Bands
JOURNAL OF NEUROIMMUNE PHARMACOLOGY . 20(1): 98-98. Nº de citas: 1
-
Rodero-Romero A, Fernández-Velasco JI, Monreal E, Sainz-Amo R, Álvarez-Lafuente R, Comabella M, Ramió-Torrentà L, García-Domínguez JM, Villarrubia N, Sainz de la Maza S, Domínguez-Mozo M, Quiroga-Varela A, Chico-García JL, Rodriguez-Jorge F, Veiga-Gonzalez JL, Roldán-Santiago E, Espiño M, Rodríguez-Martín E, Álvarez G, Masjuan J, Montalban X, Costa-Frossard L, Villar LM.
Identification of cellular factors associated with inflammation and neurodegeneration in multiple sclerosis
Frontiers in immunology . 16: 1648725-1648725. Nº de citas: 1
-
Gajate Martín L, de la Hoz I, Martín M, Fernández C, Martín Grande A, Parise D, Villahoz J, Gómez M, Espiño M, Pastor O, Rodríguez Gandía MÁ, Nuño J.
A randomized trial of ascorbic acid for the prevention of post-reperfusion syndrome during liver transplantation
Hepatology Communications . 9(8): . Nº de citas: 2
-
Monreal E, Fernández-Velasco JI, Sainz de la Maza S, Espiño M, Villarrubia N, Roldán-Santiago E, Aladro Y, Cuello JP, Ayuso-Peralta L, Rodero-Romero A, Chico-García JL, Rodríguez-Jorge F, Quiroga-Varela A, Rodríguez-Martín E, Pilo de la Fuente B, Martín-Ávila G, Martínez-Ginés ML, García-Domínguez JM, Rubio L, Llufriu S, Comabella M, Montalban X, Álvarez-Bravo G, Veiga-González JL, Masjuan J, Costa-Frossard L, Villar LM.
Combining CSF and Serum Biomarkers to Differentiate Mechanisms of Disability Worsening in Multiple Sclerosis
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 26(14): . Nº de citas: 2
-
Gómez-Ballesteros R, Sainz de la Maza S, Borges M, Martín-Martínez J, Sotoca J, Alonso A, Caminero AB, Borrega L, Sánchez-Menoyo JL, Barrero-Hernández FJ, Calles C, Brieva L, Blasco-Quílez MR, Dotor García-Soto J, Rodríguez-Regal A, Navarro-Cantó L, Agüera E, Garcés-Redondo M, Carmona O, Gabaldón-Torres L, Forero L, Hervás M, Castillo-Triviño T, Maurino J.
Threatening illness perception and associated factors in early-stage relapsing-remitting multiple sclerosis
Frontiers in psychiatry . 16: 1565150-1565150. Nº de citas: 1
-
Cayuela L, de Albóniga-Chindurza A, Gómez Enjuto S, Lapeña-Motilva J, Sainz de la Maza S, González García A, Cayuela A.
Multiple sclerosis mortality trends in Spain from 1981 to 2020.
Neurologia . 40(6): 558-566.
-
Fissolo N, Schaedelin S, Villar LM, Lünemann JD, Correale J, Rejdak K, Schwab N, Vilaseca A, Held F, García-Merino A, Bittner S, Trojano M, Furlan R, Tumani H, Pérez-Miralles F, Rosenstein I, Galimberti D, Álvarez-Bravo G, Thouvenot E, Llufriu S, Khoury SJ, Hoepner R, Martínez-Yélamos S, Hegen H, Drulovic J, Téllez-Lara N, Khalil M, Oechtering J, Pérez-Sempere Á, Rodríguez-Antigüedad A, Enrique-Martínez J, Strijbis E, Killestein J, Eichau S, Colombo E, Schaller-Nagengast J, Midaglia L, Sánchez-López AJ, Monreal E, Chan A, Paul F, Rovira À, Tintoré M, Lycke J, Zipp F, Hemmer B, Kuhle J, Montalban X, Comabella M, Zettl UK, Falk S, Gutiérrez L, Gasior M, Veiga González JL, Ferrer R, Quiroga-Varela A, Bachhuber F, Costa-Frossard L.
Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated Syndrome
JAMA NEUROLOGY . 82(7): 722-733. Nº de citas: 5
-
Cayuela L, García-Muñoz C, Sainz de la Maza S, Cayuela A.
Prevalence of multiple sclerosis in Spain. Estimates from the Primary Care Clinical Database (BDCAP).
Neurologia . 40(5): 447-455.
-
Dema M, Eixarch H, Hervera A, Castillo M, Villar LM, Montalban X, Espejo C.
Disease Aggravation With Age in an Experimental Model of Multiple Sclerosis: Role of Immunosenescence
Aging Cell . 24(5): . Nº de citas: 4
-
Oreja-Guevara C, Meca-Lallana JE, Gómez-Estévez I, Ara JR, Pérez MÁH, Gil JG, Torres AMA, de la Fuente BP, Ramió-Torrentà L, Madueño SE, Gascón-Giménez F, Casanova B, Martínez-Yélamos S, Valcárcel MA, Ginés MLM, Montero YEB, Real AML, González-Quintanilla V, de Silanes CL, Martínez-Rodríguez JE, Costa-Frossard L, Redondo MG, Fontcuberta AL, Castellanos-Pinedo F, Merino JAG, Fernández CM, Castillo-Triviño T, Meca-Lallana V, Martínez JP, Rodríguez-Antigüedad A, González JMP, Morales EA, Molina IP, Sánchez DMS, Varo NH, Vázquez MA, Barrios JMR, Río J.
Economic burden of secondary progressive multiple sclerosis: DISCOVER study.
BMC HEALTH SERVICES RESEARCH . 25(1): 525-525.